α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.
Cardiovasc Diabetol
; 16(1): 86, 2017 07 06.
Article
in En
| MEDLINE
| ID: mdl-28683829
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
1-Deoxynojirimycin
/
Diabetes Mellitus, Type 2
/
Acute Coronary Syndrome
/
Glycoside Hydrolase Inhibitors
/
Hypoglycemic Agents
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cardiovasc Diabetol
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
ENDOCRINOLOGIA
Year:
2017
Document type:
Article
Affiliation country:
Country of publication: